Details - Information last confirmed on May 7, 2021
Help Your Diabetes is a leading telemedicine company that reverses Type 2 diabetes. Its patented Type 2 Diabetes program, the only patented program of its kind, has been developed over 13 years and has helped over 8,000 patients reverse their Type 2 Diabetes.
· The only patented Type 2 Diabetes reversal program in the world, clinically proven to be successful, with over 8,000 clients having completed the program.
· Favorable market conditions, with the global telemedicine market expected to grow at a compound annual growth rate (CAGR) of 22.4% from 2021 to 2028.
· Digital platform, including online sales portal and app, to allow access to every Type 2 Diabetic in the U.S.
· Proprietary nutritional supplements developed by ownership.
· The business is structured for a fluid ownership transition.
· Heart Disease Reversal Program and Type 1 Diabetes Program in development, adding additional revenue streams.
· Expand operations into international markets, such as Central and South America, Europe, Australia and China.
· Only patented Type 2 Diabetes reversal program of its kind, allowing a tremendous opportunity to gain a large market share of the 114 million-person market in the U.S. and 463 million worldwide.
· Ramp up distributorship program that allows any healthcare professional to offer Type 2 Diabetes program.
· Dallas, Texas
· The Type 2 Diabetes program is web and mobile app-based and available to Type 2 Diabetics and Prediabetics across the U.S.
· The company operates from a 2,600 square-foot facility leased from an unrelated third party in Dallas, Texas.
· The majority owner expects to eventually make a full exit from the business to pursue other non-competing interests, but at this time would like a partial acquisition (15%-35%) to secure appropriate funding to rapidly grow the business before full acquisition occurs. After full acquisition, the majority owner agrees to stay on for a period of time to ensure a smooth transition.
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.